Mache dechanj, echanj stock jodi a
Stock quotes de 71229 konpayi nan tan reyèl.
Mache dechanj, echanj stock jodi a

Stock quotes

Stock quotes sou entènèt

Stock quotes istwa

Mache dechanj majiskil

Dividann Stock

Pwofi nan aksyon konpayi

Rapò finansye

Rating aksyon nan konpayi yo. Ki kote envesti lajan?

ImmunoCellular Therapeutics, Ltd. bouchon mache

Volim nan komès stock ImmunoCellular Therapeutics, Ltd. jodi a ak istwa a nan lèt majiskil nan ImmunoCellular Therapeutics, Ltd. Depi nan kòmansman an nan komès nan IMUC aksyon sou echanj la machandiz.
Add to widgets
Te ajoute nan widgets

ImmunoCellular Therapeutics, Ltd. lèt majiskil

Jodi a lèt majiskil sou mache a nan ImmunoCellular Therapeutics, Ltd. se 1 483 385 US dola.
+544 724 $ (+58.03%)
chanjman nan lèt majiskil depi yè

Ki sa ki majiskil nan ImmunoCellular Therapeutics, Ltd. jodi a. Chak jou, nou anrejistre yon chanjman nan majiskil ImmunoCellular Therapeutics, Ltd.. Sit entènèt nou an pran enfòmasyon nan lèt majiskil ImmunoCellular Therapeutics, Ltd. pou jounen jodi a soti nan sous louvri. ImmunoCellular Therapeutics, Ltd. majiskil = 1 483 385 dola ameriken.

ImmunoCellular Therapeutics, Ltd. volim nan komès

Jodi a volim nan komès de aksyon ImmunoCellular Therapeutics, Ltd. montan 2 100 US dola.
+1 951 $ (+1 309.40%)
chanjman nan volim nan komès depi yè

ImmunoCellular Therapeutics, Ltd. komès pran plas sou plizyè echanj valè stock. ImmunoCellular Therapeutics, Ltd. se tablo volim komès prezante sou sit entènèt la chak jou. ImmunoCellular Therapeutics, Ltd. komès holds sou anpil echanj valè echanj nan tan reyèl, nou montre volim komès la chak jou nan ImmunoCellular Therapeutics, Ltd.. ImmunoCellular Therapeutics, Ltd. majiskil grandi pa $ 544 724.

Montre:
Pou

ImmunoCellular Therapeutics, Ltd. mache bouchon tablo

ImmunoCellular Therapeutics, Ltd. majiskil sou yon graf pa ane. Pandan mwa a, ImmunoCellular Therapeutics, Ltd. majiskil te chanje pa 0%. 0% chak ane - yon chanjman nan lèt majiskil sou mache ImmunoCellular Therapeutics, Ltd.. ImmunoCellular Therapeutics, Ltd. majiskil ap grandi chak jou nan dola ameriken.

Semèn Mwa 3 mwa Ane 3 zan

ImmunoCellular Therapeutics, Ltd. Istwa kapitalizasyon

Dat Kapitalizasyon
Kapitalizasyon (mache lèt majiskil) se valè sou mache a tout aksyon nan konpayi te fè kòmès sou echanj la machandiz. Mache lèt majiskil egal a pri de aksyon miltipliye pa kantite de aksyon eksepsyonèl.
03/05/2023 1 483 385 $
02/05/2023 938 661 $
01/05/2023 1 049 907 $
28/04/2023 1 090 310 $
27/04/2023 857 151 $
25/04/2023 1 467 305 $
24/04/2023 1 422 435 $

ImmunoCellular Therapeutics, Ltd. tablo volim

Semèn Mwa 3 mwa Ane 3 zan

ImmunoCellular Therapeutics, Ltd. done istwa volim

Dat Volim (24h)
Volim komèsyal de aksyon ImmunoCellular Therapeutics, Ltd. se kantite total tout tranzaksyon ak aksyon IMUC achte ak vann pandan dat la chwazi a.
03/05/2023 2 100 $
02/05/2023 149 $
01/05/2023 745 $
28/04/2023 4 745 $
27/04/2023 202 $
25/04/2023 118 $
24/04/2023 216 $

Lèt majiskil sou mache ImmunoCellular Therapeutics, Ltd. nan 03/05/2023 montan pou 1 483 385 dola ameriken. ImmunoCellular Therapeutics, Ltd. majiskil nan 02/05/2023 egal a 938 661 dola ameriken. 01/05/2023 ImmunoCellular Therapeutics, Ltd. majiskil egal a 1 049 907 dola ameriken. ImmunoCellular Therapeutics, Ltd. majiskil egal a 1 090 310 dola ameriken nan 28/04/2023.

Lèt majiskil sou mache ImmunoCellular Therapeutics, Ltd. montan pou 857 151 dola ameriken nan 27/04/2023. ImmunoCellular Therapeutics, Ltd. majiskil nan 25/04/2023 montan pou 1 467 305 dola ameriken. 24/04/2023 ImmunoCellular Therapeutics, Ltd. majiskil montan pou 1 422 435 dola ameriken.

Lèt majiskil ImmunoCellular Therapeutics, Ltd. jodi a se 1 483 385 $. Kapitalizasyon sou mache a nan ImmunoCellular Therapeutics, Ltd. te chanje a +58.03% konpare ak yè. Volim komèsyal de aksyon IMUC nan ImmunoCellular Therapeutics, Ltd. nan dènye jou komès montan pou 2 100 $. Volim komèsyal de aksyon de ImmunoCellular Therapeutics, Ltd. chanje pou +1 309.400% konpare ak jou komès anvan an.

Pri a de aksyon ImmunoCellular Therapeutics, Ltd.

Finans ImmunoCellular Therapeutics, Ltd.